PSP Research »

BioMarin Pharmaceutical shares owned by PSP Research

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $521k 8.8k 59.43

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Norges Bank Investment Management
State Street Corporation
AQR Capital Management
Viking Global Investors
Geode Capital Management
Dimensional Fund Advisors
Millennium Management
Vestal Point Capital
Capital Research Global Investors
UBS Group
Deep Track Capital

View all funds holding BioMarin Pharmaceutical